Abstract
The Rosalind Franklin Society (RFS), in partnership with Mary Ann Liebert, Inc., publishers, enthusiastically congratulate our distinguished recipient of the 2024 annual
Dr. Claire Booth was nominated for this award based on her contributions to the Journal in her role as Associate Editor.
Biosketch
Dr. Claire Booth is Professor of pediatric immunology and gene therapy at UCL Great Ormond Street Hospital Institute of Child Health in London and leads the clinical stem cell gene therapy program at Great Ormond Street Hospital. She is a clinical academic, leading an expanding number of gene therapy clinical trials for patients with immune deficiencies, hematological, and metabolic disorders. Her research is focused on developing novel therapies for immune system disorders using innovative gene modification techniques. She has extensive experience of translating, leading, and delivering first in human clinical trials and the commercialization pathway. As an attending physician, she oversees the clinical management of patients with immune deficiencies, including hematopoietic stem cell transplantation and maintains a strong interest in HLH disorders.
Claire is an elected board member of the European and American Societies of Gene and Cell Therapy, serves on the editorial board of several journals and grant review committees, and holds an honorary position at Boston Children’s Hospital and Harvard Medical School.
She is also the co-founder of the AGORA Foundation (Access to Gene Therapies for Rare Diseases) which brings together European academic developers and patient organizations, aiming to facilitate access to effective gene therapies for treatment of patients with ultra-rare diseases.